Literature DB >> 9010994

Pathogenesis of ruminant herpesvirus infections.

M Engels1, M Ackermann.   

Abstract

Ruminants are hosts for members of both Alpha- and Gamma-herpesvirinae. A wide range of disease syndromes is associated with infections by these agents. The associated diseases reflect the biological nature of the causative viruses. Clinically, the symptoms may be mild and localized or include severe generalized disease, leading eventually to death. Much knowledge has been gained concerning the pathogenesis of some alpha-herpesviruses. Initially, these viruses replicate in epithelial cells at the portal of entry. The symptoms of the acute diseases are often associated with the destruction of those epithelial cells. However, as in the case of bovine herpesvirus 1 (BHV-1), the virus may spread in the infected host by viremia, gaining access to a broader range of tissues and organs, and causing a broader variety of diseases. Furthermore, many herpesviruses are capable of entering neuronal cells. There, they may replicate, which may lead to neuronal diseases, for example, encephalitis. In addition, the herpesviruses may establish latency in neuronal or lymphoid cells. During latency, apparently no viral antigens are synthesized but the genomes of the latent viruses are present in the nuclei of long living cells, such as, e.g., neurones of the ganglia corresponding to the sites of peripheral replication. Upon reactivation, the viruses re-establish the lytic cycle of replication. Shielded from the effectors of the immune system, they migrate back to the peripheral tissues where they are excreted and may be transmitted. Although a strong immune response is provoked during primary viral replication, these mechanisms help the herpesviruses to escape from immune surveillance during latency and to a lesser degree during reactivation. It has been observed that certain herpesviruses may behave differently upon infection of different hosts. Relatively little progress has been made concerning the understanding of the pathogenesis of ruminant herpesviruses but much has been learned about viral molecular biology. Many viral proteins have been identified and characterized and the technology to create recombinant viruses has been established. With these tools in our hands, it is now possible to address the really interesting questions concerning pathogenesis. We postulate that herpesviruses contain at least two sets of genes, a first set involved in gene expression and viral replication, and a second set responsible for functions, which may affect pathogenesis, latency, and virus/host interactions. Using recombinant virus technology, it will be possible in the future to design targeted deletions and gene transfers in ruminant herpesviruses in order to study the viral and host factors involved in pathogenesis on the molecular level.

Entities:  

Mesh:

Year:  1996        PMID: 9010994     DOI: 10.1016/s0378-1135(96)01230-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  21 in total

Review 1.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

2.  Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain.

Authors:  Evgeni Gabev; Kurt Tobler; Carlos Abril; Monika Hilbe; Claudia Senn; Marco Franchini; Gabriella Campadelli-Fiume; Cornel Fraefel; Mathias Ackermann
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

3.  Bovine herpesvirus 6 in buffaloes (Bubalus bulalis) from the Amazon region, Brazil.

Authors:  Cairo Henrique Sousa de Oliveira; Fernanda Gonçalves de Oliveira; Marcela Ribeiro Gasparini; Grazielle Cossenzo Florentino Galinari; Graciela Kunrath Lima; Antônio Augusto Fonseca; José Diomedes Barbosa; Edel Figueiredo Barbosa-Stancioli; Rômulo Cerqueira Leite; Jenner Karlisson Pimenta Dos Reis
Journal:  Trop Anim Health Prod       Date:  2014-11-27       Impact factor: 1.559

4.  Cervid herpesvirus 2 causes respiratory and fetal infections in semidomesticated reindeer.

Authors:  Carlos G das Neves; Espen Rimstad; Morten Tryland
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

5.  Experimental infection of reindeer with cervid herpesvirus 2.

Authors:  Carlos G das Neves; Torill Mørk; Jacques Godfroid; Karen K Sørensen; Eva Breines; Ellinor Hareide; Julien Thiry; Espen Rimstad; Etienne Thiry; Morten Tryland
Journal:  Clin Vaccine Immunol       Date:  2009-10-21

6.  Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice.

Authors:  Carlos Abril; Monika Engels; Anne Liman; Monika Hilbe; Sarah Albini; Marco Franchini; Mark Suter; Mathias Ackermann
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  A trypsin-like serine protease is involved in pseudorabies virus invasion through the basement membrane barrier of porcine nasal respiratory mucosa.

Authors:  Sarah Glorieux; Herman W Favoreel; Lennert Steukers; Annelies P Vandekerckhove; Hans J Nauwynck
Journal:  Vet Res       Date:  2011-04-14       Impact factor: 3.683

8.  Using scenario tree modelling for targeted herd sampling to substantiate freedom from disease.

Authors:  Sarah Blickenstorfer; Heinzpeter Schwermer; Monika Engels; Martin Reist; Marcus G Doherr; Daniela C Hadorn
Journal:  BMC Vet Res       Date:  2011-08-16       Impact factor: 2.741

9.  Biphasic activation of PI3K/Akt and MAPK/Erk1/2 signaling pathways in bovine herpesvirus type 1 infection of MDBK cells.

Authors:  Liqian Zhu; Xiuyan Ding; Xiaofang Zhu; Songshu Meng; Jianye Wang; Hong Zhou; Qiangde Duan; Jie Tao; Dieter M Schifferli; Guoqiang Zhu
Journal:  Vet Res       Date:  2011-04-14       Impact factor: 3.683

10.  Cloning of Bovine herpesvirus type 1 and type 5 as infectious bacterial artifical chromosomes.

Authors:  Evgeni Gabev; Cornel Fraefel; Mathias Ackermann; Kurt Tobler
Journal:  BMC Res Notes       Date:  2009-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.